Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$92.6M
-
Value change
-
-$2.49M
-
Put/Call ratio
-
0.02
-
Number of buys
-
25
-
Number of sells
-
-28
-
Price
-
$5.03
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q2 2023
65 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q2 2023.
Apyx Medical Corp - Common Stock (APYX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 35M outstanding shares and own 52.65% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.45M shares), Divisadero Street Capital Management, LP (2.28M shares), RTW INVESTMENTS, LP (1.78M shares), ROYCE & ASSOCIATES LP (1.6M shares), VANGUARD GROUP INC (1.48M shares), AIGH Capital Management LLC (1.27M shares), PURA VIDA INVESTMENTS, LLC (989K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), Cowen Prime Advisors LLC (606K shares), and Taylor Frigon Capital Management LLC (536K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.